Everolimus-Facilitated Reduction Of Tacrolimus Provides Comparable Efficacy And Superior Renal Function Versus Standard Tacrolimus In De Novo Liver Transplant Recipients: 24-Month Results Of A Randomized Trial

被引：0

作者：

Saliba, Faouzi ^{[1
]}

De Simone, Paolo ^{[2
]}

Nevens, Frederik ^{[3
]}

De Carlis, Luciano ^{[4
]}

Metselaar, Herold ^{[5
]}

Beckebaum, Susanne ^{[6
]}

Jonas, Sven ^{[7
]}

Sudan, Debra ^{[8
]}

Fischer, Lutz ^{[9
]}

Fung, John J. ^{[10
]}

Dong, Gaohong ^{[11
]}

Lopez, Patricia M. ^{[12
]}

Junge, Guido ^{[12
]}

机构：

[1] Hop Paul Brousse, Villejuif, France

[2] Azienda Osped Univ Pisana, Pisa, Italy

[3] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Louvain, Belgium

[4] Osped Niguarda Ca Granda, Milan, Italy

[5] Univ Rotterdam Hosp, Erasmus MC, Rotterdam, Netherlands

[6] Univ Hosp Essen, Essen, Germany

[7] Univ Med Ctr Leipzig, Leipzig, Germany

[8] Duke Univ, Med Ctr, Durham, NC USA

[9] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany

[10] Cleveland Clin Fdn, Cleveland, OH 44195 USA

[11] Novartis Pharmaceut, E Hanover, NJ USA

[12] Novartis Pharma AG, Basel, Switzerland

来源：

HEPATOLOGY | 2012年 / 56卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

LB5

引用

页码：1519 / 1519

页数：1

共 50 条

[21] Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients: 24-month Results From the Pooled Analysis of 2 Randomized Controlled Trials
Lee, Sung-Gyu
Jeng, Long-Bin
Saliba, Faouzi
Soin, Arvinder Singh
Lee, Wei-Chen
De Simone, Paolo
Nevens, Frederik
Suh, Kyung-Suk
Fischer, Lutz
Joo, Dong Jin
Fung, John
Joh, Jae-Won
Kaido, Toshimi
Grant, David
Meier, Matthias
Rauer, Barbara
Sips, Carole
Kaneko, Shuhei
Levy, Gary
TRANSPLANTATION, 2021, 105 (07) : 1564 - 1575
[22] EVEROLIMUS-BASED IMMUNOSUPPRESSION IN HCV POSITIVE DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMIZED CONTROLLED TRIAL
Saliba, F.
Metselaar, H. J.
Beckebaum, S.
Duvoux, C.
Navasa, M.
Dong, G.
Lopez, P.
Nevens, F.
JOURNAL OF HEPATOLOGY, 2013, 58 : S79 - S80
[23] Effects of Everolimus and Tacrolimus Exposure on Efficacy and Renal Function in Liver Transplant Recipients at 24 Months in a Randomized Trial (H2304)
Fischer, L.
Kaiser, G.
Koneru, B.
Toselli, L.
Durand, F.
Heaton, N.
Shetty, K.
Dong, G.
Lopez, P.
Junge, G.
Kovarik, J.
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 117 - 118
[24] Exposure-Response Analysis of Everolimus and Tacrolimus in De Novo Liver Transplant Recipients: 24-Month Results from the H2304 Study.
Fischer, L.
Kaiser, G. M.
Huang, M. A.
Toselli, L.
Durand, F.
Heaton, N.
Shetty, K.
Klintmalm, G.
Dong, G.
Lopez, P.
Junge, G.
Kovarik, J. M.
LIVER TRANSPLANTATION, 2013, 19 : S148 - S148
[25] Everolimus with Reduced Tacrolimus Exposure Versus Standard Tacrolimus in Hepatitis C Virus Positive De Novo Liver Transplant Recipients.
Saliba, F.
De Simone, P.
De Carlis, L.
Metselaar, H. J.
Beckebaum, S.
Jonas, S.
Sudan, D.
Fung, J.
Fischer, L.
Huang, M. A.
Wang, Y.
Sips, C.
Lopez, P.
Nevens, F.
LIVER TRANSPLANTATION, 2012, 18 : S98 - S98
[26] EFFICACY AND SAFETY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: 12 MONTH RESULTS OF A PHASE III, RANDOMIZED, CONTROLLED STUDY
Saliba, Faouzi
De Simone, Paolo
Nevens, Frederik
De Carlis, Luciano
Metselaar, Herold
Beckebaum, Susanne
Jonas, Sven
Sudan, Debra
Fischer, Lutz
Fung, John J.
Jiang, Hai
Junge, Guido
HEPATOLOGY, 2011, 54 : 1430A - 1431A
[27] EVEROLIMUS-BASED IMMUNOSUPPRESSION PROVIDES SUPERIOR RENAL FUNCTION AND COMPARABLE EFFICACY VERSUS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANTATION: 3-YEAR RESULTS FROM H2304 STUDY EXTENSION
Saliba, F.
Kaiser, G. M.
De Carlis, L.
Metselaar, H. J.
De Simone, P.
Duvoux, C.
Nevens, F.
Fischer, L.
Fung, J.
Dong, G.
Rauer, B.
Junge, G.
JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S362 - S362
[28] Efficacy and Safety of Everolimus With Low-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Randomized Study
Qazi, Y.
Shaffer, D.
Kaplan, B.
Kim, D.
Luan, F.
Peddi, V.
Shihab, F.
Tomlanovich, S.
Yilmaz, S.
McCague, K.
Patel, D.
Mulgaonkar, S.
TRANSPLANTATION, 2014, 98 : 80 - 80
[29] Efficacy of Everolimus with Reduced Cyclosporine in Japanese De Novo Renal Transplant Recipients: 24-Month, Randomized, Multicenter Study.
Saito, K.
Uchida, K.
Takahara, S.
Yoshimura, N.
Teraoka, S.
Cornu-Artis, C.
Kobayashi, E.
Takahashi, K.
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 314 - 314
[30] Efficacy and Safety of Everolimus With Low-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Randomized Study
Qazi, Y.
Shaffer, D.
Kaplan, B.
Kim, D.
Luan, F.
Peddi, V.
Shihab, F.
Tomlanovich, S.
Yilmaz, S.
McCague, K.
Patel, D.
Mulgaonkar, S.
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 80 - 80

← 1 2 3 4 5 →